Clinuvel Pharmaceuticals Limited Receivables

Clinuvel Pharmaceuticals Limited (CLVLY) currently reports a receivables of $17M as of December 2025. That compares with $16M in the prior-year period — up 1.7% year over year. Use the charts on this page to explore Clinuvel Pharmaceuticals Limited's receivables history and peer comparisons.

Clinuvel Pharmaceuticals Limited's receivables increased from $16M to $17M — a 1.7% year-over-year increase (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Clinuvel Pharmaceuticals Limited reported $17M in receivables as of December 2025. That compares with $16M in the prior-year period — up 1.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $17M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Clinuvel Pharmaceuticals Limited, and consider following CLVLY for alerts when major investors trade the stock.

Clinuvel Pharmaceuticals Limited is classified in the Healthcare sector. On receivables, it currently shows $17M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CLVLY with unrelated industries.